bifidumbacterin-eco powder lyophilized for oral solution and topical application
ecopolis cjsc - lyophilized viable bacteria bifidobacterium bifidum 791 - powder lyophilized for oral solution and topical application - 107 cfu
broncho-vaxom
om pharma s.a. r. da industria, 2, 2610-088 amadora, lisboa, portugal - lyophilized bacterial, lysates - capsule - lyophilized bacterial lysates 7 mg - other respiratory system products
broncho-vaxom
om pharma s.a. r. da industria, 2, 2610-088 amadora, lisboa, portugal - lyophilized bacterial, lysates - capsule - lyophilized bacterial lysates 3.5 mg - other respiratory system products
immubron
bruschettini s.r.l. via isonzo 6 - 16147 genova, italy - lyophilized bacterial, lysates - tablet - lyophilized bacterial lysates 50 mg - vaccines
green-viii inj. lyophilized powder for solution for injection (iv)
vizcarra pharmaceutical, incorporated; distributor: vizcarra pharmaceutical, incorporated - human coagulation factor viii - lyophilized powder for solution for injection (iv) - 250 iu (25 iu/ml) lyophilized powder for solution for injection (iv)
happy living lyophilized royal jelly 500 mg
happy living sdn bhd - lyophilized royal jelly -
ramezole 40 mg lyophilized lyophilized powder for injection
sahar international trading, inc.; distributor: amson pharmaceuticals - omeprazole (as sodium) - lyophilized powder for injection - 40 mg lyophilized
empliciti elotuzumab 400mg lyophilized powder for iv infusion vial
bristol-myers squibb australia pty ltd - elotuzumab, quantity: 440 mg - injection, powder for - excipient ingredients: sodium citrate dihydrate; citric acid monohydrate; sucrose; polysorbate 80; water for injections - empliciti (elotuzumab) is indicated in combination with lenalidomide and dexamethasone for the treatment of patients with multiple myeloma who have received at least one prior therapy.
empliciti elotuzumab 300mg lyophilized powder for iv infusion vial
bristol-myers squibb australia pty ltd - elotuzumab, quantity: 340 mg - injection, powder for - excipient ingredients: sodium citrate dihydrate; citric acid monohydrate; sucrose; polysorbate 80; water for injections - empliciti (elotuzumab) is indicated in combination with lenalidomide and dexamethasone for the treatment of patients with multiple myeloma who have received at least one prior therapy.
nahazole 40 mg lyophilized lyophilized powder for injection
sahar international trading, inc.; distributor: nahal pharmaceutical - omeprazole (as sodium) - lyophilized powder for injection - 40 mg lyophilized